Navigation Links
Researchers close in on new melanoma gene
Date:5/19/2008

Phoenix, Arizona and Queensland, Australia It has long been known that prolonged exposure to the suns harmful UV rays can lead to Melanoma, the deadliest form of skin cancer. An unanswered question, however, is why some people are more likely to develop melanoma than others. Despite years of research and clinical development, melanoma incidences continue to rise around the world. According to the National Cancer Institute, the percentage of people in the United States who develop melanoma each year has more than doubled in the past 30 years.

Results published today from a study led by researchers from The Translational Genomic Research Institute (TGen) in Phoenix, Arizona and The Queensland Institute of Medical Research (QIMR), Queensland, Australia, however, may yet change these statistics. The team is close to discovering a new gene that could help explain variation in melanoma risk.

In a report appearing in an Advance Online Publication (AOP) of the journal Nature Genetics, the researchers and their colleagues identify a region on chromosome 20 (20q11.22) that influences a persons risk of developing melanoma.

According to Dr Kevin Brown, TGen Investigator and the papers co-first author, compared to other genetic research focusing on familial (or inherited) cases of melanoma, this finding holds implications for the general population

Were closing in on genetic variants which cause 16 percent of the population to be at nearly double the increased risk of developing the disease. In public health terms, this finding is highly significant, Dr. Brown said.

The researchers narrowed the gene location through a genome-wide association study a first in melanoma research. Genome-wide studies involve rapidly scanning DNA of many people to find genetic variations associated with a particular disease. After identifying new genetic associations, researchers can use the information to develop better strategies to detect, treat and prevent the disease.

The aim of our work is to identify and understand the genetic factors influencing melanoma so we can better predict risk estimates, said QIMRs Dr. Stuart MacGregor, co-first author on the study. This in turn, means people will be better informed and can take the right precautions to avoid developing this increasingly common cancer.

How The Study Works A genome-wide association study involves scanning the DNA from two sets of individuals: those with a particular disease (cases) and those of similar individuals without the disease (controls). The DNA of each sample then undergoes examination for strategically selected markers of genetic variation, called single nucleotide polymorphisms, or SNPs. If certain genetic variations are found to be significantly more frequent in people with the disease compared to people without disease, those variations are said to be "associated" with the disease. The associated genetic variations can serve as roadmaps to the region of the human genome where the disease-causing gene resides.

The study whose data collection began 20 years ago involved more than 4,000 Australian samples (2,019 cases and 2,105 controls) and was a joint project between Australian, American and European research groups.


'/>"/>

Contact: Galen Perry
gperry@tgen.org
602-343-8423
The Translational Genomics Research Institute
Source:Eurekalert

Related medicine news :

1. Traditional herbal medicine kills pancreatic cancer cells, Jefferson researchers report
2. Researchers develop first transgenic monkey model of Huntingtons disease
3. Researchers expand natural killer cells in cord blood to fight leukemia
4. Medical College of Wisconsin researchers identify proteins that help develop mammalian hearts
5. Mastectomies on the rise and MRI use may explain part of the trend, say Mayo researchers
6. UCSD researchers show link between vitamin D status, breast cancer
7. Researchers find first conclusive evidence of Alzheimers-like brain tangles in nonhuman primates
8. Vancouver researchers discover missing link between TB bacteria and humans
9. 1 of the best researchers in general practice
10. Researchers fine-tune clot-busting treatment for bleeding in brain
11. OHSU Cancer Institute researchers pinpoint how smoking causes cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... ... among Pittsburgh-area schoolchildren has found that more than 40 percent of participating fifth-grade ... MD , Director of Allergy and Asthma Clinical Research in the Division of ...
(Date:5/5/2016)... (PRWEB) , ... May 05, 2016 , ... Dr. Benjamin ... in non-surgical hair loss treatment. Dr. Stong is double board certified and the ... for the treatment of hair loss. Non-surgical therapies such as stem cells can ...
(Date:5/5/2016)... ... May 05, 2016 , ... The 2016 Nike Soccer Camp will be directed ... university coaching staff. Together they bring their winning Vandals coaching philosophy to young athletes. ... ages 5-13, and high school players. Session dates are as follows: , Youth Day ...
(Date:5/5/2016)... ... May 05, 2016 , ... When stiff and achy joints ... the pain that’s a common osteoarthritis (OA) symptom. Yet, numerous clinical studies point ... arthritis. , “Physical therapy exercises are commonly prescribed to individuals with osteoarthritis ...
(Date:5/5/2016)... ... ... Lung Institute will celebrate its three-year anniversary on May 14 by giving away ... month of May. To date, the Lung Institute has treated over 2,000 people at their ... testament to the success of this treatment and to the patients who refuse to give ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... , May 4, 2016 ... across 154 pages, profiling 09 key companies and ... a professional and in-depth study on the current ... basic overview of the industry including definitions, classifications, ... market analysis is provided for the international market ...
(Date:5/3/2016)... , May 3, 2016  Axiogenesis has acquired a major investment from Sino-German High-Tech Fund to further expand ... Photo - http://photos.prnewswire.com/prnh/20160503/362921 ... ... ... ...
(Date:5/3/2016)... , May 3, 2016   BIOTRONIK ... technology, today announced Food and Drug Administration (FDA) ... defibrillator that provides heart failure patients with access ... devices also have remote monitoring with daily automatic ... the heart rate in response to physiological demands. ...
Breaking Medicine Technology: